Self-expandable metal stents for recurrent malignant obstruction after gastric surgery

Jeong Kim Hong, Youp Park Jeong, Seungmin Bang, Woo Park Seung, Yongchan Lee, Young Song Si

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background/Aims: It is well known that endoscopic insertion of self-expandable metallic stents (SEMS) is safe and effective for the palliative treatment of malignant strictures involving the upper gastrointestinal tract. But, most previous studies focused on stent insertion for esophageal or gastroduodenal obstructions. Only a few cases of stent insertion for recurrent malignant obstruction after gastric cancer surgery have been reported in studies in fewer than 40 patients. The aim of this study was to evaluate the clinical effectiveness of the placement of SEMS in patients with anastomotic recurrence after gastric cancer surgery and compare the clinical outcome according to stent and operation type. Methodology: The data were collected from 47 patients in whom SEMS were placed by endoscopic approach for recurrent malignant obstruction after gastric cancer surgery. Technical and clinical success and complications according to operation and stent type were evaluated. Also, Overall survival and stent patency rates were calculated. Results: Stent placement was technically successful in 45 of the 47 patients (95.7%). After stent placement, 91.5% of the patients showed improvement in their dietary intake level. A statistically significant improvement in overall Gastric Outlet Obstruction Scoring System between pre- and post-procedure was noted (p<0.001). Stent failure occurred in 13 patients (stent migration: 4; tumor overgrowth: 1; tumor ingrowth: 8). The median survival and stent patency period were 101 days and 63 days, respectively. Conclusions: SEMS insertion in patients with anastomotic recurrence of gastric cancer after gastric cancer surgery is technically feasible and clinically effective.

Original languageEnglish
Pages (from-to)914-917
Number of pages4
JournalHepato-Gastroenterology
Volume56
Issue number91-92
Publication statusPublished - 2009 May 1

Fingerprint

Stents
Stomach
Stomach Neoplasms
Self Expandable Metallic Stents
Gastric Outlet Obstruction
Recurrence
Upper Gastrointestinal Tract
Survival
Palliative Care
Neoplasms
Pathologic Constriction

All Science Journal Classification (ASJC) codes

  • Gastroenterology
  • Hepatology

Cite this

Hong, J. K., Jeong, Y. P., Bang, S., Seung, W. P., Lee, Y., & Si, Y. S. (2009). Self-expandable metal stents for recurrent malignant obstruction after gastric surgery. Hepato-Gastroenterology, 56(91-92), 914-917.
Hong, Jeong Kim ; Jeong, Youp Park ; Bang, Seungmin ; Seung, Woo Park ; Lee, Yongchan ; Si, Young Song. / Self-expandable metal stents for recurrent malignant obstruction after gastric surgery. In: Hepato-Gastroenterology. 2009 ; Vol. 56, No. 91-92. pp. 914-917.
@article{31596915e26e4e64b57d7d3272db36c8,
title = "Self-expandable metal stents for recurrent malignant obstruction after gastric surgery",
abstract = "Background/Aims: It is well known that endoscopic insertion of self-expandable metallic stents (SEMS) is safe and effective for the palliative treatment of malignant strictures involving the upper gastrointestinal tract. But, most previous studies focused on stent insertion for esophageal or gastroduodenal obstructions. Only a few cases of stent insertion for recurrent malignant obstruction after gastric cancer surgery have been reported in studies in fewer than 40 patients. The aim of this study was to evaluate the clinical effectiveness of the placement of SEMS in patients with anastomotic recurrence after gastric cancer surgery and compare the clinical outcome according to stent and operation type. Methodology: The data were collected from 47 patients in whom SEMS were placed by endoscopic approach for recurrent malignant obstruction after gastric cancer surgery. Technical and clinical success and complications according to operation and stent type were evaluated. Also, Overall survival and stent patency rates were calculated. Results: Stent placement was technically successful in 45 of the 47 patients (95.7{\%}). After stent placement, 91.5{\%} of the patients showed improvement in their dietary intake level. A statistically significant improvement in overall Gastric Outlet Obstruction Scoring System between pre- and post-procedure was noted (p<0.001). Stent failure occurred in 13 patients (stent migration: 4; tumor overgrowth: 1; tumor ingrowth: 8). The median survival and stent patency period were 101 days and 63 days, respectively. Conclusions: SEMS insertion in patients with anastomotic recurrence of gastric cancer after gastric cancer surgery is technically feasible and clinically effective.",
author = "Hong, {Jeong Kim} and Jeong, {Youp Park} and Seungmin Bang and Seung, {Woo Park} and Yongchan Lee and Si, {Young Song}",
year = "2009",
month = "5",
day = "1",
language = "English",
volume = "56",
pages = "914--917",
journal = "Acta hepato-splenologica",
issn = "0172-6390",
publisher = "H.G.E. Update Medical Publishing Ltd.",
number = "91-92",

}

Hong, JK, Jeong, YP, Bang, S, Seung, WP, Lee, Y & Si, YS 2009, 'Self-expandable metal stents for recurrent malignant obstruction after gastric surgery', Hepato-Gastroenterology, vol. 56, no. 91-92, pp. 914-917.

Self-expandable metal stents for recurrent malignant obstruction after gastric surgery. / Hong, Jeong Kim; Jeong, Youp Park; Bang, Seungmin; Seung, Woo Park; Lee, Yongchan; Si, Young Song.

In: Hepato-Gastroenterology, Vol. 56, No. 91-92, 01.05.2009, p. 914-917.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Self-expandable metal stents for recurrent malignant obstruction after gastric surgery

AU - Hong, Jeong Kim

AU - Jeong, Youp Park

AU - Bang, Seungmin

AU - Seung, Woo Park

AU - Lee, Yongchan

AU - Si, Young Song

PY - 2009/5/1

Y1 - 2009/5/1

N2 - Background/Aims: It is well known that endoscopic insertion of self-expandable metallic stents (SEMS) is safe and effective for the palliative treatment of malignant strictures involving the upper gastrointestinal tract. But, most previous studies focused on stent insertion for esophageal or gastroduodenal obstructions. Only a few cases of stent insertion for recurrent malignant obstruction after gastric cancer surgery have been reported in studies in fewer than 40 patients. The aim of this study was to evaluate the clinical effectiveness of the placement of SEMS in patients with anastomotic recurrence after gastric cancer surgery and compare the clinical outcome according to stent and operation type. Methodology: The data were collected from 47 patients in whom SEMS were placed by endoscopic approach for recurrent malignant obstruction after gastric cancer surgery. Technical and clinical success and complications according to operation and stent type were evaluated. Also, Overall survival and stent patency rates were calculated. Results: Stent placement was technically successful in 45 of the 47 patients (95.7%). After stent placement, 91.5% of the patients showed improvement in their dietary intake level. A statistically significant improvement in overall Gastric Outlet Obstruction Scoring System between pre- and post-procedure was noted (p<0.001). Stent failure occurred in 13 patients (stent migration: 4; tumor overgrowth: 1; tumor ingrowth: 8). The median survival and stent patency period were 101 days and 63 days, respectively. Conclusions: SEMS insertion in patients with anastomotic recurrence of gastric cancer after gastric cancer surgery is technically feasible and clinically effective.

AB - Background/Aims: It is well known that endoscopic insertion of self-expandable metallic stents (SEMS) is safe and effective for the palliative treatment of malignant strictures involving the upper gastrointestinal tract. But, most previous studies focused on stent insertion for esophageal or gastroduodenal obstructions. Only a few cases of stent insertion for recurrent malignant obstruction after gastric cancer surgery have been reported in studies in fewer than 40 patients. The aim of this study was to evaluate the clinical effectiveness of the placement of SEMS in patients with anastomotic recurrence after gastric cancer surgery and compare the clinical outcome according to stent and operation type. Methodology: The data were collected from 47 patients in whom SEMS were placed by endoscopic approach for recurrent malignant obstruction after gastric cancer surgery. Technical and clinical success and complications according to operation and stent type were evaluated. Also, Overall survival and stent patency rates were calculated. Results: Stent placement was technically successful in 45 of the 47 patients (95.7%). After stent placement, 91.5% of the patients showed improvement in their dietary intake level. A statistically significant improvement in overall Gastric Outlet Obstruction Scoring System between pre- and post-procedure was noted (p<0.001). Stent failure occurred in 13 patients (stent migration: 4; tumor overgrowth: 1; tumor ingrowth: 8). The median survival and stent patency period were 101 days and 63 days, respectively. Conclusions: SEMS insertion in patients with anastomotic recurrence of gastric cancer after gastric cancer surgery is technically feasible and clinically effective.

UR - http://www.scopus.com/inward/record.url?scp=67651236977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67651236977&partnerID=8YFLogxK

M3 - Article

VL - 56

SP - 914

EP - 917

JO - Acta hepato-splenologica

JF - Acta hepato-splenologica

SN - 0172-6390

IS - 91-92

ER -